Twist Bioscience Corp (TWST)
30.75
-0.75
(-2.38%)
USD |
NASDAQ |
Apr 24, 16:00
30.65
-0.10
(-0.33%)
After-Hours: 20:00
Twist Bioscience Revenue (Quarterly): 71.50M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 71.50M |
| September 30, 2023 | 66.95M |
| June 30, 2023 | 63.74M |
| March 31, 2023 | 60.18M |
| December 31, 2022 | 54.24M |
| September 30, 2022 | 57.31M |
| June 30, 2022 | 56.11M |
| March 31, 2022 | 48.13M |
| December 31, 2021 | 42.02M |
| September 30, 2021 | 37.95M |
| June 30, 2021 | 35.02M |
| March 31, 2021 | 31.20M |
| December 31, 2020 | 28.16M |
| Date | Value |
|---|---|
| September 30, 2020 | 32.43M |
| June 30, 2020 | 21.21M |
| March 31, 2020 | 19.30M |
| December 31, 2019 | 17.16M |
| September 30, 2019 | 15.74M |
| June 30, 2019 | 13.60M |
| March 31, 2019 | 13.56M |
| December 31, 2018 | 11.49M |
| September 30, 2018 | 8.407M |
| June 30, 2018 | 6.541M |
| March 31, 2018 | 6.166M |
| December 31, 2017 | 4.313M |
| September 30, 2017 | 3.466M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
13.60M
Minimum
Jun 2019
71.50M
Maximum
Dec 2023
40.63M
Average
37.95M
Median
Sep 2021
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -5.239M |
| Retractable Technologies Inc | 14.29M |
| Xtant Medical Holdings Inc | 28.11M |
| Asensus Surgical Inc | 5.431M |
| Catheter Precision Inc | 0.128M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -43.01M |
| Total Expenses (Quarterly) | 118.48M |
| EPS Diluted (Quarterly) | -0.75 |
| Enterprise Value | 1.467B |
| Gross Profit Margin (Quarterly) | 40.51% |
| Profit Margin (Quarterly) | -60.15% |
| Earnings Yield | -11.74% |
| Normalized Earnings Yield | -11.05 |